Pdb82 - Re-Analysis of the Diabetes Prevention Program (Dpp) 3 Year Cost-Effectiveness Analysis (Cea) Using Identical Data but Proper Qaly Calculations May Revive Its Metformin Conclusions

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.787
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pdb80 - Re-Analysis of the Diabetes Prevention Program 3 Year Cost-Effectiveness Analysis (Cea) Using Identical Data but Proper Methods Questions Its Conclusions

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prm107 - Can Accounting for Missing Data Cast Doubt on Previous Conclusions Reevaluating a 10 Year Cost-Effectiveness Analysis (Cea) of the Diabetes Prevention Program Outcomes Study (Dpp/Dppos)?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pdb85 - A 10 Year Cost-Effectiveness Analysis (Cea) of the Diabetes Prevention Program Outcomes Study (Dpp/Dppos): Clarifying the Previous Confusion

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention: An Intent-To-Treat Analysis of the DPP/DPPOS

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2012English

PDB49 Cost Benefit Analysis of a Diabetes Prevention Program in Rural Kenya

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

845 Cost-Effectiveness Analysis in Fire Prevention

Injury Prevention
EnvironmentalPublic HealthOccupational Health
2016English

Evaluating the Cost-Effectiveness of Lifestyle Modification Versus Metformin Therapy for the Prevention of Diabetes in Singapore

PLoS ONE
Multidisciplinary
2014English

A Systematic Review of Cost-Effectiveness Analysis (CEA) Studies From the Patient’s Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy